Displaying 1 - 11 of 11
| Active Ingredient | BUDESONIDE | FORMOTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Treatment of asthma. |
| Caution | Beta blockers including eye drops can weaken the effect of the inhaler. Ketoconazole may increase systemic exposure to the budesonide component. Use with caution in patients with cardiovascular disea More ... |
| Dose Range | Adults and Children 12 years and older: 1-2 inhalations once or twice daily . See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BUDESONIDE | FORMOTEROL (120 R) |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BUDESONIDE | FORMOTEROL (120) |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BUDESONIDE | FORMOTEROL (60) |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BUDESONIDE | FORMOTEROL (R) |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE | SALMETEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Asthma, chronic obstructive pulmonary disease. |
| Caution | Growth suppression, abdominal pain, dyspepsia, candidiasis, osteoporosis, back pain, cataract, glaucoma, chest congestion, hoarseness |
| Dose Range |
Asthma: Adults and Children 12 years and older: 1 inhalation twice daily (50/100, 50/250, 50/500) or 2 inhalations twice daily (25/50, 25/125, 25/250), based on asthma severity . Age 4-11: 1 Inhalation twice daily (50/100) or 2 p uffs tw |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE | VILANTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Long-term maintenance of airflow obstruction in p atients with chronic obstructive pulmonary disease (COPD). |
| Caution |
Close monitoring for glaucoma and cataracts is warranted. Do not use in combination with an additional LABA because of risk of overdose. Naso-pharyngitis, upper respiratory tract infection, hea More ... |
| Dose Range | One inhalation once daily at the same time each day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FORMOTEROL | MOMETASONE |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IPRATROPIUM | SALBUTAMOL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications |
Treating moderate-to-severe COPD; it is indicated primarily in patients who fail to resp ond on ipratropium alone. The role of the combination in acute asthma is unclear. |
| Caution | Tachycardia, dry mouth, Bronchitis, upper respiratory tract infections and headache. |
| Dose Range |
Two inhalations four times daily is indicated in chronic obstructive pulmonary disease. In severe acute asthma, ipratropium 0.5mg/salbutamol 2.5mg via nebulizer has been administered. See BDS supply protocols pg. 10. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MOMETASONE | FORMOTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | As for budesonide/formoterol. |
| Caution | Nasopharyngitis, sinusitis, headache. |
| Dose Range |
Adults and Children 12 years and older: Two inhalations twice daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | UMECLIDINIUM | VILANTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Moderate to severe chronic obstructive pulmonary disease (COPD). |
| Caution | As for Vilanterol/Fluticasone; The inhaler should be discarded 6 weeks after opening. |
| Dose Range | One inhalation once daily at the same time each day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |